Assessing the Effect of Guduchi and Punarnava on Pandu roga W.S.R. to Iron Deficiency Anaemia in Women: A Clinical Study

Abstract

The investigation into the therapeutic efficacy of Guduchi and Punarnava in the management of Pandu Roga, specifically in the context of iron deficiency anemia among women, is underscored by a well-structured clinical study designed to address a significant health concern. The primary aim of this study is to evaluate the effects of these two notable Ayurvedic herbs, which are traditionally reputed for their hematogenic and rejuvenating properties. The materials and methods deployed in this clinical trial involved a systematic selection of female participants diagnosed with iron deficiency anemia, thereby ensuring a homogeneous study population that would yield robust results. This was achieved through rigorous screening and stratification according to established diagnostic criteria, ensuring that the interventions effects could be accurately measured against control groups receiving standard treatment modalities. The findings of the study are anticipated to contribute both qualitatively and quantitatively to the existing body of research, indicating not only improvements in hemoglobin levels and red blood cell counts but also addressing symptomatic relief, thus presenting a dual benefit to the participants.

The originality of this study lies in its integrative approach to traditional Ayurvedic practices with contemporary clinical methodologies, bridging a gap often found between alternative and conventional medical paradigms. The implications of these findings could be profound, suggesting that the incorporation of Ayurvedic formulations like Guduchi and Punarnava may offer a viable alternative or adjunct to conventional treatments, thereby promoting a more holistic approach to managing iron deficiency anemia. Such insights are crucial in expanding the therapeutic arsenal available for clinicians, particularly in settings where iron supplementation may be met with challenges related to patient compliance or adverse reactions, as highlighted in the existing literature.